| Filed On | Filing |
|---|---|
| 15 May 2023 |
8-K/A: Financial Statements and Exhibits
On February 28, 2023, Cytek Biosciences, Inc. (the “Company” or “acquirer”) acquired certain assets and liabilities related to the flow cytometry and imaging business unit (the “FCI business unit”) from Luminex Corporation (“Luminex”), a... |
Loading...
